Unia Europejska - polski - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - szczepionki - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. stosowanie tej szczepionki powinno odbywać się zgodnie z oficjalnymi zaleceniami.

Unia Europejska - polski - EMA (European Medicines Agency)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - szczepionki - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Polska - polski - Ministerstwo Rolnictwa i Rozwoju Wsi

syngenta polska sp. z o.o._x000d_ ul. szamocka, 01-748 warszawa - azoksystrobina - azoksystrobina - 250 g - fungicyd

Polska - polski - Ministerstwo Rolnictwa i Rozwoju Wsi

syngenta polska sp. z o.o._x000d_ ul. szamocka, 01-748 warszawa - tiofanat metylowy; epoksykonazol - azoksystrobina - 250 g - fungicyd

Polska - polski - Ministerstwo Rolnictwa i Rozwoju Wsi

cbc (europe) s.r.l._x000d_ via zanica, 25-24050 grassobbio (bg), włochy - bacillus thuringiensis subsp. kurstaki; szczep eg 2348 - bacillus thuringiensis subsp. kurstaki, szczep eg 2348 - 150 g - insektycyd

Polska - polski - Ministerstwo Rolnictwa i Rozwoju Wsi

madez- firma handlowo-usługowa mariusz rudnicki myśliborska, 74-240 lipiany - acetamipryd - acetamipryd - 20 % - insektycyd

Polska - polski - Ministerstwo Rolnictwa i Rozwoju Wsi

danstar ferment ag_x000d_ poststrasse, ch-6300 zug, szwajcaria - gliocladium catenulatum - gliocladium catenulatum - 32 % - fungicyd

Polska - polski - Ministerstwo Rolnictwa i Rozwoju Wsi

arysta lifescience benelux sprl_x000d_ rue de renory, b-4102 ougre (seraing), królestwo belgii - propamokarb w postaci kompleksu z chlorowodorem - propamokarb w postaci kompleksu z chlorowodorem - 722 g - fungicyd

Polska - polski - Ministerstwo Rolnictwa i Rozwoju Wsi

sharda cropchem ltd._x000d_ prime business park dashrathlal joshi road, vile parle (west), 400 056 mumbai, republika indii - metaldehyd - metaldehyd - 30 g - moluskocyd

Polska - polski - Ministerstwo Rolnictwa i Rozwoju Wsi

syngenta agro gmbh regional headquarters_x000d_ technologiepark, d-63477 maintal, republika federalna niemiec - azoksystrobina; difenokonazol - azoksystrobina - 200 g, _x000d_ difenokonazol - 125 g - fungicyd